Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Validation of wearable bioelectronic sensors

Official title: Evaluation of Wearable Multi-modality Sensors for Monitoring Vital Signs

Run by University of North Carolina, Chapel Hill · NCT05397951 · Data updated 2026-11-12

This study tests new wearable sensors to see if they are safe and work well while people do different activities, including exercise.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment22 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedJanuary 9, 2024
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedApril 17, 2026
Trial IDNCT05397951 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy individuals aged 18 to 99 without significant illnesses.

Probably not a fit

Patients with active skin disorders, allergies to adhesives, or those unable to perform moderate exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safe wearability and basic functions of innovative, multi-modality wearable sensors developed in the lab. Participants will wear these sensors alongside approved medical devices to record various physiological measurements during different activities, including exercise. The aim is to validate the sensors' safety and functionality, providing preliminary data that could lead to future studies focused on specific disease models. Participants will return for follow-up visits to monitor any potential adverse events related to the devices.

Why it matters

Potential benefit: If successful, this study could lead to the development of advanced wearable devices that provide continuous, non-invasive health monitoring.

How similar studies have gone: While the approach of using wearable sensors is gaining traction, this specific validation study is novel and aims to establish foundational data for future applications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals with ages between 18 and 99.
* Healthy individuals (not known to suffer any significant illness relevant to the proposed study).

Exclusion Criteria:

* Pregnant or lactating.
* History of active (clinically significant) skin disorders that make skin vulnerable to contact conventional electronic devices.
* History of allergic response to silicones or adhesives (such as 3M Tegaderm).
* Broken, damaged or irritated skin or rashes near the sensor application sites (finger, wrist, temple, subclavian, arm, neck, and thigh).
* Subjects who are physically or cognitively unable to normally perform activities of daily living, assessed at the discretion of the investigator to ensure safe completion of study tasks.
* Subjects who are unable to participate in moderate exercise for 6 minutes.

Where it's running

  • Kenan Laboratories at the University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Wubin Bai, PhD — Assistant Professor of Applied Physical Sciences
  • Study coordinator: Hannah L Weisbecker, BS
  • Email: hannahlw@alumni.unc.edu
  • Phone: 6786417484

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.